LEADER 03305nam 22006135 450 001 9910253860903321 005 20200705025330.0 010 $a3-319-27347-7 024 7 $a10.1007/978-3-319-27347-1 035 $a(CKB)3710000000616284 035 $a(EBL)4452729 035 $a(OCoLC)945613280 035 $a(SSID)ssj0001653366 035 $a(PQKBManifestationID)16433198 035 $a(PQKBTitleCode)TC0001653366 035 $a(PQKBWorkID)14982712 035 $a(PQKB)10235240 035 $a(DE-He213)978-3-319-27347-1 035 $a(MiAaPQ)EBC4452729 035 $a(PPN)192774166 035 $a(EXLCZ)993710000000616284 100 $a20160315d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aClinical Pharmacology: Current Topics and Case Studies /$fedited by Markus Müller 205 $a2nd ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (398 p.) 300 $aDescription based upon print version of record. 311 $a3-319-27345-0 320 $aIncludes bibliographical references and index. 327 $aThe discipline of Clinical Pharmacology -- Current issues in drug development -- Current issues in drug regulation -- Current issues in drug reimbursement -- Ethics of clinical research -- GCP, Scientific misconduct -- Phases of drug development, first in man studies -- Clinical trials - Interventional studies -- Clinical trials - observational studies -- Imaging -- Microdosing -- Genomics -- Pharmacokinetics/Pharmacodynamics -- Epidemiology, statistics -- Placebo effects -- Pharmaceutical drug safety -- Drug interactions -- Advanced therapies -- Biological pharmaceuticals -- Generic drugs, Enantiomers -- Special situations I: orphan drugs -- Special situations II: sex differences -- Special situations III: children. 330 $aThis revised and extended second edition focuses on current and emerging topics in drug development, their molecular mechanisms of action as well as regulatory issues. In addition, in-depth insights into clinical drug research and trial methodology are presented on the basis of concrete case studies. This updated book makes a valuable contribution to the field of Clinical Pharmacology and serves as a must-have guide for professors, researchers and advanced students from academia and pharmaceutical industry. . 606 $aPharmacology 606 $aPharmacy 606 $aPharmacotherapy 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 606 $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008 606 $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000 615 0$aPharmacology. 615 0$aPharmacy. 615 0$aPharmacotherapy. 615 14$aPharmacology/Toxicology. 615 24$aPharmacy. 615 24$aPharmacotherapy. 676 $a610 702 $aMüller$b Markus$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910253860903321 996 $aClinical Pharmacology: Current Topics and Case Studies$92526692 997 $aUNINA